logo

For the Inventor, By the Inventor

Ottawa, Canada

James Matthew Symonds

This inventor holds 17 USPTO granted patents, primarily in Cancer Therapeutics. Top assignee: Adherex Technologies, Inc.. Active years: 2000-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Matthew Symonds. Retrieved from https://idiyas.com/inventor/james-matthew-symonds

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 82.4

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 174(Granted Patents)


Location History:

  • Ottawa, CA (2000 - 2005)
  • Durham, NC (US) (2009)

Company Filing History:

goldMedal17 out of 31 
 
Adherex Technologies, Inc.
 patents

Years Active: 2000-2009

Loading Chart...
Areas of Expertise:
OB-Cadherin
Claudin
Cancer Therapy
Metastasis Inhibition
Cadherin-5
Desmosomal Cadherin
Tissue Permeability
Junctional Adhesion Molecule
Cancer Diagnosis
Cell Adhesion
Nonclassical Cadherin
17 patents (USPTO):Explore Patents
1. 7481999 - Compounds and methods for modulating OB-cadherin-mediated function (2009-01-27),
2. 6962969 - Compounds and methods for modulating nonclassical cadherin-mediated functions (2005-11-08),
3. 6830894 - Compounds and methods for modulating claudin-mediated functions (2004-12-14),
4. 6797807 - Compounds and methods for cancer therapy (2004-09-28),
5. 6756356 - Compounds and methods for modulating claudin-mediated functions (2004-06-29),
6. 6723700 - Compounds and methods for modulating claudin-mediated functions (2004-04-20),
7. 6682901 - Methods for diagnosing and evaluating cancer (2004-01-27),
8. 6680175 - Methods for diagnosing and evaluating cancer (2004-01-20),
9. 6638911 - Compounds and methods for modulating desmosomal cadherin-mediated functions (2003-10-28),
10. 6593297 - Compounds and methods for inhibiting cancer metastasis (2003-07-15),
11. 6569996 - Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence (2003-05-27),
12. 6472367 - Compounds and methods for modulating OB-cadherin mediated cell adhesion (2002-10-29),
13. 6433149 - Compounds and methods for inhibiting cancer metastasis (2002-08-13),
14. 6391855 - Compounds and methods for modulating junctional adhesion molecule-mediated functions (2002-05-21),
15. 6310177 - Compounds and methods for modulating tissue permeability (2001-10-30),

Title: James Matthew Symonds: Pioneering Inventor from Ottawa, CA

Introduction: James Matthew Symonds is a renowned inventor based in Ottawa, Canada, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: James Matthew Symonds holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: With a career spanning over two decades, James Matthew Symonds has worked for leading tech companies, research institutions, and universities, where he has spearheaded numerous projects that have resulted in significant technological advancements.

Collaborations: Throughout his career, James Matthew Symonds has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: James Matthew Symonds continues to push the boundaries of innovation, with his passion for creating transformative technologies that have the potential to shape the future of various industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…